Core Insights - Borui Pharmaceutical announced an investment of 50 million yuan in Suzhou Geek Gene Technology Co., Ltd, acquiring a 12.8015% stake after the capital increase [1] Company Overview - Geek Gene is an innovative cell drug development company specializing in high-throughput omics data to regulate cell fate [1] - The company primarily focuses on single-cell sequencing services and the development of immune cell therapies [1] Product Focus - Geek Gene is currently concentrating on developing long-lived tumor-reactive T cell drugs aimed at treating advanced solid tumors [1]